| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 1.000 | None | 0.983 | 120 | 24 | 2000 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 1.000 | None | 1.000 | 24 | 4 | 1994 | 2019 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 1.000 | strong | 0.957 | 23 | 20 | 1995 | 2015 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.800 | None | 1.000 | 29 | 7 | 1987 | 2017 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.800 | strong | 1.000 | 29 | 4 | 2009 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.600 | limited | 1.000 | 13 | 0 | 2010 | 2018 | ||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
disease | 0.600 | limited | 0 | 1 | |||||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
disease | 0.550 | None | 1.000 | 6 | 1 | 2013 | 2017 | ||||||||
|
RAS related | 0.543 | 0.808 | 4.7E-03 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.400 | None | 1.000 | 29 | 0 | 1994 | 2017 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.380 | None | 1.000 | 9 | 0 | 2011 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.380 | None | 1.000 | 9 | 0 | 1997 | 2018 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2015 | 2019 | ||||||||
|
Janus kinase 3 | 0.505 | 0.731 | 5.9E-06 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2015 | ||||||||
|
Rac family small GTPase 2 | 0.556 | 0.731 | 0.97 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
RAS related 2 | 0.656 | 0.500 | 0.97 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | 0.751 | 0.231 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.260 | None | 1.000 | 6 | 0 | 2004 | 2017 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2009 | 2018 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2005 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1986 | 2014 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1997 | 2018 |